Literature DB >> 27649773

Subanesthetic ketamine decreases the incentive-motivational value of reward-related cues.

Christopher J Fitzpatrick1, Jonathan D Morrow1,2.   

Abstract

The attribution of incentive-motivational value to reward-related cues contributes to cue-induced craving and relapse in addicted patients. Recently, it was demonstrated that subanesthetic ketamine increases motivation to quit and decreases cue-induced craving in cocaine-dependent individuals. Although the underlying mechanism of this effect is currently unknown, one possibility is that subanesthetic ketamine decreases the incentive-motivational value of reward-related cues. In the present study, we used a Pavlovian conditioned approach procedure to identify sign-trackers, rats that attribute incentive-motivational value to reward-related cues, and goal-trackers, rats that assign only predictive value to reward-related cues. This model is of interest because sign-trackers are more vulnerable to cue-induced reinstatement of drug-seeking behavior and will persist in this drug-seeking behavior despite adverse consequences. We tested the effect of subanesthetic ketamine on the expression of Pavlovian conditioned approach behavior and the conditioned reinforcing properties of a reward-related cue in sign- and goal-trackers. We found that subanesthetic ketamine decreased sign-tracking and increased goal-tracking behavior in sign-trackers, though it had no effect on conditioned reinforcement. These results suggest that subanesthetic ketamine may be a promising pharmacotherapy for addiction that acts by decreasing the incentive-motivational value of reward-related cues.

Entities:  

Keywords:  Pavlovian conditioned approach; addiction; conditioned reinforcement; salience; sign-tracking

Mesh:

Substances:

Year:  2016        PMID: 27649773      PMCID: PMC5453722          DOI: 10.1177/0269881116667709

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.562


  62 in total

1.  Antidepressant, mood stabilizing and procognitive effects of very low dose sublingual ketamine in refractory unipolar and bipolar depression.

Authors:  Diogo R Lara; Luisa W Bisol; Luciano R Munari
Journal:  Int J Neuropsychopharmacol       Date:  2013-05-20       Impact factor: 5.176

2.  Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers.

Authors:  A Breier; A K Malhotra; D A Pinals; N I Weisenfeld; D Pickar
Journal:  Am J Psychiatry       Date:  1997-06       Impact factor: 18.112

3.  Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.

Authors:  B Moghaddam; B Adams; A Verma; D Daly
Journal:  J Neurosci       Date:  1997-04-15       Impact factor: 6.167

4.  Distinct effects of ventral tegmental area NMDA and acetylcholine receptor blockade on conditioned reinforcement produced by food-associated cues.

Authors:  R J Wickham; W B Solecki; E J Nunes; N A Addy
Journal:  Neuroscience       Date:  2015-06-17       Impact factor: 3.590

5.  Attentional shifts to smoking cues in smokers.

Authors:  Andrew J Waters; Saul Shiffman; Brendan P Bradley; Karin Mogg
Journal:  Addiction       Date:  2003-10       Impact factor: 6.526

6.  Test-retest reliability of the BOLD pharmacological MRI response to ketamine in healthy volunteers.

Authors:  S De Simoni; A J Schwarz; O G O'Daly; A F Marquand; C Brittain; C Gonzales; S Stephenson; S C R Williams; M A Mehta
Journal:  Neuroimage       Date:  2012-09-23       Impact factor: 6.556

7.  Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression.

Authors:  Marije aan het Rot; Katherine A Collins; James W Murrough; Andrew M Perez; David L Reich; Dennis S Charney; Sanjay J Mathew
Journal:  Biol Psychiatry       Date:  2010-01-15       Impact factor: 13.382

8.  Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors.

Authors:  Sungho Maeng; Carlos A Zarate; Jing Du; Robert J Schloesser; Joseph McCammon; Guang Chen; Husseini K Manji
Journal:  Biol Psychiatry       Date:  2007-07-23       Impact factor: 13.382

9.  Ketamine reverses stress-induced depression-like behavior and increased GABA levels in the anterior cingulate: an 11.7 T 1H-MRS study in rats.

Authors:  Shane A Perrine; Farhad Ghoddoussi; Mark S Michaels; Imran S Sheikh; George McKelvey; Matthew P Galloway
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-11-15       Impact factor: 5.067

10.  Lateral prefrontal model-based signatures are reduced in healthy individuals with high trait impulsivity.

Authors:  L Deserno; T Wilbertz; A Reiter; A Horstmann; J Neumann; A Villringer; H-J Heinze; F Schlagenhauf
Journal:  Transl Psychiatry       Date:  2015-10-13       Impact factor: 6.222

View more
  4 in total

1.  The role of glutamate signaling in incentive salience: second-by-second glutamate recordings in awake Sprague-Dawley rats.

Authors:  Seth R Batten; Francois Pomerleau; Jorge Quintero; Greg A Gerhardt; Joshua S Beckmann
Journal:  J Neurochem       Date:  2018-05-15       Impact factor: 5.372

2.  Disconnection of basolateral amygdala and insular cortex disrupts conditioned approach in Pavlovian lever autoshaping.

Authors:  Helen M Nasser; Danielle S Lafferty; Ellen N Lesser; Sam Z Bacharach; Donna J Calu
Journal:  Neurobiol Learn Mem       Date:  2017-11-21       Impact factor: 2.877

3.  Subanesthetic ketamine with an AMPAkine attenuates motor impulsivity in rats.

Authors:  Brionna D Davis-Reyes; Ashley E Smith; Jimin Xu; Kathryn A Cunningham; Jia Zhou; Noelle C Anastasio
Journal:  Behav Pharmacol       Date:  2021-06-01       Impact factor: 2.277

4.  Individual variation in the attribution of incentive salience to social cues.

Authors:  Christopher J Fitzpatrick; Jonathan D Morrow
Journal:  Sci Rep       Date:  2020-02-13       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.